Global And Japan Intravitreal Injectable Market Insights, Forecast To 2027

1 Study Coverage
1.1 Intravitreal Injectable Product Introduction
1.2 Market by Drug
1.2.1 Global Intravitreal Injectable Market Size Growth Rate by Drug
1.2.2 Anti-VEGF
1.2.3 Steroids
1.2.4 Others
1.3 Market by Disease
1.3.1 Global Intravitreal Injectable Market Size Growth Rate by Disease
1.3.2 Macular Degeneration
1.3.3 Macular Edema
1.3.4 Uveitis
1.3.5 Retinal Vein Occlusion
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Intravitreal Injectable Market Size, Estimates and Forecasts
2.1.1 Global Intravitreal Injectable Revenue 2016-2027
2.1.2 Global Intravitreal Injectable Sales 2016-2027
2.2 Global Intravitreal Injectable, Market Size by Region: 2016 VS 2022 VS 2027
2.3 Intravitreal Injectable Historical Market Size by Region (2016-2022)
2.3.1 Global Intravitreal Injectable Retrospective Market Scenario in Sales by Region: 2016-2022
2.3.2 Global Intravitreal Injectable Retrospective Market Scenario in Revenue by Region: 2016-2022
2.4 Intravitreal Injectable Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Intravitreal Injectable Sales Forecast by Region (2022-2027)
2.4.2 Global Intravitreal Injectable Revenue Forecast by Region (2022-2027)

3 Global Intravitreal Injectable Competitor Landscape by Players
3.1 Global Top Intravitreal Injectable Manufacturers by Sales
3.1.1 Global Intravitreal Injectable Sales by Manufacturer (2016-2022)
3.1.2 Global Intravitreal Injectable Sales Market Share by Manufacturer (2016-2022)
3.2 Global Top Intravitreal Injectable Manufacturers by Revenue
3.2.1 Key Intravitreal Injectable Manufacturers Covered: Ranking by Revenue
3.2.2 Global Intravitreal Injectable Revenue by Manufacturers (2016-2022)
3.2.3 Global Intravitreal Injectable Revenue Share by Manufacturers (2016-2022)
3.2.4 Global Intravitreal Injectable Market Concentration Ratio (CR5 and HHI) (2016-2022)
3.2.5 Global Top 10 and Top 5 Companies by Intravitreal Injectable Revenue in 2020
3.2.6 Global Intravitreal Injectable Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Intravitreal Injectable Price by Manufacturers
3.4 Global Intravitreal Injectable Manufacturing Base Distribution, Product Types
3.4.1 Intravitreal Injectable Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Intravitreal Injectable Product Type
3.4.3 Date of International Manufacturers Enter into Intravitreal Injectable Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Drug (2016-2027)
4.1 Global Intravitreal Injectable Market Size by Drug (2016-2022)
4.1.1 Global Intravitreal Injectable Sales by Drug (2016-2022)
4.1.2 Global Intravitreal Injectable Revenue by Drug (2016-2022)
4.1.3 Intravitreal Injectable Average Selling Price (ASP) by Drug (2016-2022)
4.2 Global Intravitreal Injectable Market Size Forecast by Drug (2022-2027)
4.2.1 Global Intravitreal Injectable Sales Forecast by Drug (2022-2027)
4.2.2 Global Intravitreal Injectable Revenue Forecast by Drug (2022-2027)
4.2.3 Intravitreal Injectable Average Selling Price (ASP) Forecast by Drug (2022-2027)

5 Breakdown Data by Disease (2016-2027)
5.1 Global Intravitreal Injectable Market Size by Disease (2016-2022)
5.1.1 Global Intravitreal Injectable Sales by Disease (2016-2022)
5.1.2 Global Intravitreal Injectable Revenue by Disease (2016-2022)
5.1.3 Intravitreal Injectable Price by Disease (2016-2022)
5.2 Intravitreal Injectable Market Size Forecast by Disease (2022-2027)
5.2.1 Global Intravitreal Injectable Sales Forecast by Disease (2022-2027)
5.2.2 Global Intravitreal Injectable Revenue Forecast by Disease (2022-2027)
5.2.3 Global Intravitreal Injectable Price Forecast by Disease (2022-2027)

6 Japan by Players, Drug and Disease
6.1 Japan Intravitreal Injectable Market Size YoY Growth 2016-2027
6.1.1 Japan Intravitreal Injectable Sales YoY Growth 2016-2027
6.1.2 Japan Intravitreal Injectable Revenue YoY Growth 2016-2027
6.1.3 Japan Intravitreal Injectable Market Share in Global Market 2016-2027
6.2 Japan Intravitreal Injectable Market Size by Players (International and Local Players)
6.2.1 Japan Top Intravitreal Injectable Players by Sales (2016-2022)
6.2.2 Japan Top Intravitreal Injectable Players by Revenue (2016-2022)
6.3 Japan Intravitreal Injectable Historic Market Review by Drug (2016-2022)
6.3.1 Japan Intravitreal Injectable Sales Market Share by Drug (2016-2022)
6.3.2 Japan Intravitreal Injectable Revenue Market Share by Drug (2016-2022)
6.3.3 Japan Intravitreal Injectable Price by Drug (2016-2022)
6.4 Japan Intravitreal Injectable Market Estimates and Forecasts by Drug (2022-2027)
6.4.1 Japan Intravitreal Injectable Sales Forecast by Drug (2022-2027)
6.4.2 Japan Intravitreal Injectable Revenue Forecast by Drug (2022-2027)
6.4.3 Japan Intravitreal Injectable Price Forecast by Drug (2022-2027)
6.5 Japan Intravitreal Injectable Historic Market Review by Disease (2016-2022)
6.5.1 Japan Intravitreal Injectable Sales Market Share by Disease (2016-2022)
6.5.2 Japan Intravitreal Injectable Revenue Market Share by Disease (2016-2022)
6.5.3 Japan Intravitreal Injectable Price by Disease (2016-2022)
6.6 Japan Intravitreal Injectable Market Estimates and Forecasts by Disease (2022-2027)
6.6.1 Japan Intravitreal Injectable Sales Forecast by Disease (2022-2027)
6.6.2 Japan Intravitreal Injectable Revenue Forecast by Disease (2022-2027)
6.6.3 Japan Intravitreal Injectable Price Forecast by Disease (2022-2027)

7 North America
7.1 North America Intravitreal Injectable Market Size YoY Growth 2016-2027
7.2 North America Intravitreal Injectable Market Facts & Figures by Country
7.2.1 North America Intravitreal Injectable Sales by Country (2016-2022)
7.2.2 North America Intravitreal Injectable Revenue by Country (2016-2022)
7.2.3 United States
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Intravitreal Injectable Market Size YoY Growth 2016-2027
8.2 Asia Pacific Intravitreal Injectable Market Facts & Figures by Region
8.2.1 Asia Pacific Intravitreal Injectable Sales by Region (2016-2022)
8.2.2 Asia Pacific Intravitreal Injectable Revenue by Region (2016-2022)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia

9 Europe
9.1 Europe Intravitreal Injectable Market Size YoY Growth 2016-2027
9.2 Europe Intravitreal Injectable Market Facts & Figures by Country
9.2.1 Europe Intravitreal Injectable Sales by Country (2016-2022)
9.2.2 Europe Intravitreal Injectable Revenue by Country (2016-2022)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Intravitreal Injectable Market Size YoY Growth 2016-2027
10.2 Latin America Intravitreal Injectable Market Facts & Figures by Country
10.2.1 Latin America Intravitreal Injectable Sales by Country (2016-2022)
10.2.2 Latin America Intravitreal Injectable Revenue by Country (2016-2022)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Intravitreal Injectable Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Intravitreal Injectable Market Facts & Figures by Country
11.2.1 Middle East and Africa Intravitreal Injectable Sales by Country (2016-2022)
11.2.2 Middle East and Africa Intravitreal Injectable Revenue by Country (2016-2022)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE

12 Company Profiles
12.1 Regeneron Pharmaceuticals (Eylea)
12.1.1 Regeneron Pharmaceuticals (Eylea) Corporation Information
12.1.2 Regeneron Pharmaceuticals (Eylea) Description and Business Overview
12.1.3 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Sales, Revenue and Gross Margin (2016-2022)
12.1.4 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Products Offered
12.1.5 Regeneron Pharmaceuticals (Eylea) Recent Development
12.2 Allergan
12.2.1 Allergan Corporation Information
12.2.2 Allergan Description and Business Overview
12.2.3 Allergan Intravitreal Injectable Sales, Revenue and Gross Margin (2016-2022)
12.2.4 Allergan Intravitreal Injectable Products Offered
12.2.5 Allergan Recent Development
12.3 EyePoint Pharmaceuticals
12.3.1 EyePoint Pharmaceuticals Corporation Information
12.3.2 EyePoint Pharmaceuticals Description and Business Overview
12.3.3 EyePoint Pharmaceuticals Intravitreal Injectable Sales, Revenue and Gross Margin (2016-2022)
12.3.4 EyePoint Pharmaceuticals Intravitreal Injectable Products Offered
12.3.5 EyePoint Pharmaceuticals Recent Development
12.4 Genentech
12.4.1 Genentech Corporation Information
12.4.2 Genentech Description and Business Overview
12.4.3 Genentech Intravitreal Injectable Sales, Revenue and Gross Margin (2016-2022)
12.4.4 Genentech Intravitreal Injectable Products Offered
12.4.5 Genentech Recent Development
12.5 Kanghong Pharmaceutical
12.5.1 Kanghong Pharmaceutical Corporation Information
12.5.2 Kanghong Pharmaceutical Description and Business Overview
12.5.3 Kanghong Pharmaceutical Intravitreal Injectable Sales, Revenue and Gross Margin (2016-2022)
12.5.4 Kanghong Pharmaceutical Intravitreal Injectable Products Offered
12.5.5 Kanghong Pharmaceutical Recent Development
12.11 Regeneron Pharmaceuticals (Eylea)
12.11.1 Regeneron Pharmaceuticals (Eylea) Corporation Information
12.11.2 Regeneron Pharmaceuticals (Eylea) Description and Business Overview
12.11.3 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Sales, Revenue and Gross Margin (2016-2022)
12.11.4 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Products Offered
12.11.5 Regeneron Pharmaceuticals (Eylea) Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Intravitreal Injectable Industry Trends
13.2 Intravitreal Injectable Market Drivers
13.3 Intravitreal Injectable Market Challenges
13.4 Intravitreal Injectable Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Intravitreal Injectable Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.